StockData
LeonaBio, Inc. logo

LeonaBio, Inc. (LONA) stock

LONANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$2.65−0.11 (-3.99%)

Close on Nov 18, 2026Market cap $24.97MP/E –Yield –

LeonaBio total assets

Total assets on the balance sheet at the end of each period.

LeonaBio's total assets was $56.89M at Jun 30, 2026. For fiscal 2025 it was $92.15M, up 56.8% from the year before. The highest annual figure on record is $332.01M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$92.15M+56.8%
FY2024Dec 31, 2024$58.78M-63.3%
FY2023Dec 31, 2023$160.25M-37.9%
FY2022Dec 31, 2022$258.15M-22.2%
FY2021Dec 31, 2021$332.01M+18.8%
FY2020Dec 31, 2020$279.56M+12671.3%
FY2019Dec 31, 2019$2.19M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$56.89M+60.1%
Q1 FY2026Mar 31, 2026$71.59M+64.5%
Q4 FY2025Dec 31, 2025$92.15M+56.8%
Q3 FY2025Sep 30, 2025$30.03M-65.2%
Q2 FY2025Jun 30, 2025$35.55M-68.1%
Q1 FY2025Mar 31, 2025$43.51M-67.4%
Q4 FY2024Dec 31, 2024$58.78M-63.3%
Q3 FY2024Sep 30, 2024$86.25M-53.3%
Q2 FY2024Jun 30, 2024$111.25M-46.5%
Q1 FY2024Mar 31, 2024$133.46M-42.7%
Q4 FY2023Dec 31, 2023$160.25M-37.9%
Q3 FY2023Sep 30, 2023$184.70M-32.6%
Q2 FY2023Jun 30, 2023$208.05M-28.8%
Q1 FY2023Mar 31, 2023$232.77M-25.6%
Q4 FY2022Dec 31, 2022$258.15M-22.2%
Q3 FY2022Sep 30, 2022$274.19M-21.1%
Q2 FY2022Jun 30, 2022$292.01M-18.9%
Q1 FY2022Mar 31, 2022$313.00M-15.3%
Q4 FY2021Dec 31, 2021$332.01M+18.8%
Q3 FY2021Sep 30, 2021$347.33M+29.6%
Q2 FY2021Jun 30, 2021$360.12M+16351.5%
Q1 FY2021Mar 31, 2021$369.41M–
Q4 FY2020Dec 31, 2020$279.56M–
Q3 FY2020Sep 30, 2020$267.94M–
Q4 FY2019Dec 31, 2019$2.19M–

More LeonaBio figures

See a number that looks wrong?